Stifel Nicolaus Downgrades Idenix Pharmaceuticals (IDIX) to Sell
Tweet Send to a FriendGet Alerts IDIX Hot Sheet
Price: $5.29 --0%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 16
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 16
Trade IDIX Now!
Stifel Nicolaus downgraded Idenix Pharmaceuticals (NASDAQ: IDIX) from Hold to Sell.
For an analyst ratings summary and ratings history on Idenix Pharmaceuticals click here. For more ratings news on Idenix Pharmaceuticals click here.
Shares of Idenix Pharmaceuticals closed at $14.33 yesterday, with a 52 week range of $2.67-$15.25.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Idenix Pharmaceuticals click here. For more ratings news on Idenix Pharmaceuticals click here.
Shares of Idenix Pharmaceuticals closed at $14.33 yesterday, with a 52 week range of $2.67-$15.25.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BofA/Merrill Lynch Downgrades Cliffs Natural Resources (CLF) to Underperform
- UPDATE: Macquarie Downgrades Sprint (S) to Neutral
- BMO Capital Downgrades Tesaro (TSRO) to Market Perform
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
Stifel Nicolaus
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
